SCYX compared with ZVRA: revenue, margins and what each company keeps, and the suppliers and customers both name

SCYXScynexis Inc

Mkt capRevenueRevenue

ZVRAZevra Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

SCYXScynexis Inc

ZVRAZevra Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

SCYX: latest quarter not drawable.Method ›

Price

rebased to 0%

SCYX, solidZVRA, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SCYX 4

—Merckunlistedsupplier

—GlaxoSmithKline Intellectual Property (No. 3) Limited (GSK)unlistedcustomer

—Hansohunlistedcustomer

—R-Pharmunlistedcustomer

Shared 0

No shared counterparties.

Only ZVRA 6

—Aquestive Therapeuticsunlistedsupplier

—Orphazyme A/Sunlistedsupplier

—Reliefunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

Xoma

unlistedsupplier

2 more · ZVRA chain ›

SCYXScynexis Inc

3.78▼−2.20%· post 3.71

Mkt cap$37.5MRevenue$235,000Q2 FY26Revenue$21MFY25

ZVRAZevra Therapeutics, Inc.

10.28▼−0.73%· post 10.28

ClosedOct 30 '26

Mkt cap$610.5MRevenue$40MQ2 FY26Revenue$106MFY25

Compare

ClosedOct 30 '26

SCYXScynexis Inc

ZVRAZevra Therapeutics, Inc.

3.78▼−2.20%post 3.71

Price

10.28▼−0.73%post 10.28

$37.5M

Mkt cap

$610.5M

Q2 FY26$235,000

Revenue

$40MQ2 FY26

FY25$21M

Revenue

$106MFY25

SCYX3.78▼−2.20%vsZVRA10.28▼−0.73%ClosedOct 30 '26